Who
Ross Fubini
Director
Company insider
Files Form 4 as: Director, Ginkgo Bioworks Holdings; Director, Home Plate Acquisition.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 30 Mar 2023
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 11 Jun 2026filed 15 Jun 2026 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 12 Jun 2025filed 13 Jun 2025 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,375 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,822 | filing |
| 11 Jun 2025filed 13 Jun 2025 | DNA Ginkgo Bioworks HoldingsBiotechnology | SEC FORM 4 Code M | —10,822 | filing |
| 13 Jun 2024filed 14 Jun 2024 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,111,111 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —571,428 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | DNA Ginkgo Bioworks Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —432,900 at $0.00 | filing |
| 30 Mar 2023filed 26 Jun 2023 | Home Plate Acquisitionoption or derivative | SEC FORM 4 Code C | —25,000 at $0.00 | filing |
| 30 Mar 2023filed 26 Jun 2023 | Home Plate Acquisition | SEC FORM 4 Code C | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.